Brimonidine and Moxetumomab pasudotox-tdfk Intravenous
Determining the interaction of Brimonidine and Moxetumomab pasudotox-tdfk Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: brimonidine ophthalmic
Brand name: Alphagan P, Lumify, Alphagan
Synonyms: Brimonidine ophthalmic, Brimonidine (Ophthalmic)
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab pasudotox, Moxetumomab Pasudotox
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Brimonidine-Moxifloxacin
- Brimonidine-Moxifloxacin (Systemic)
- Brimonidine-Moxifloxacin Hydrochloride
- Brimonidine-Moxifloxacin Injection
- Brimonidine-Moxifloxacin Intravenous
- Brimonidine-Moxifloxacin Tablets
- Moxetumomab pasudotox-tdfk Intravenous-Brimonidine and brinzolamide ophthalmic
- Moxetumomab pasudotox-tdfk Intravenous-Brimonidine and Timolol
- Moxetumomab pasudotox-tdfk Intravenous-Brimonidine and timolol ophthalmic
- Moxetumomab pasudotox-tdfk Intravenous-Brimonidine ophthalmic
- Moxetumomab pasudotox-tdfk Intravenous-Brimonidine Tartrate eent
- Moxetumomab pasudotox-tdfk Intravenous-Brimonidine Tartrate topical